Genetic Polymorphisms of Estrogen Receptor- : Possible Implications for Targeted Osteoporosis Therapy

Author： Ongphiphadhanakul B.  

Publisher： Adis International

ISSN： 1175-2203

Source： American Journal of PharmacoGenomics, Vol.3, Iss.1, 2003-01, pp. : 5-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Distinct Functions of Retinoic Acid Receptor Beta Isoforms: Implications for Targeted Therapy

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 8, Iss. 1, 2008-03 ,pp. : 47-50

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of Polymorphisms of the CYP450 Enzyme Genes on Estrogen Status and the Risk for Osteoporosis

By  

Current Pharmacogenomics, Vol. 5, Iss. 1, 2007-03 ,pp. : 1-10

Bentham Science Publishers

Access to resources Recommend Favorite

Polymorphisms of Estrogen Receptors and Risk of Depression: Therapeutic Implications

By Ryan Joanne   Ancelin Marie-Laure  

Drugs, Vol. 72, Iss. 13, 2012-09 ,pp. : 1725-1738

Adis International

Access to resources Recommend Favorite

Selective Estrogen Receptor Modulators for Postmenopausal Osteoporosis: Current State of Development

By Gennari Luigi   Merlotti Daniela   Valleggi Fabrizio   Martini Giuseppe   Nuti Ranuccio  

Drugs & Aging, Vol. 24, Iss. 5, 2007-01 ,pp. : 361-379

Adis International

Access to resources Recommend Favorite

Estrogen Receptor Beta in Cancer: an Attractive Target for Therapy

By  

Current Pharmaceutical Design, Vol. 18, Iss. 19, 2012-06 ,pp. : 2734-2757

Bentham Science Publishers

Access to resources Recommend Favorite